Bleak Q4 figures hit Aurobindo Pharma
DALAL STREET SPIKES

Explore Business Standard
DALAL STREET SPIKES

| The counter witnessed volumes of more than 59 thousand shares at the BSE and 1.88 lakh shares at the NSE. Analysts said, disappointing Q4 results propelled selling by market participants. |
| The company for the quarter ended March 31 reported a decline in net profit at Rs 36.22 crore as against Rs 46.37 crore in the same period last year. |
| The counter was also under selling pressure on overall weakness in the market sentiment as investors are looking at exit options at every higher levels. |
| For the year ended March 31, the company's net profit stood at Rs 127.01 crore as against Rs 103.14 crore on total income of Rs 1,363.13 crore. |
First Published: Jun 04 2004 | 12:00 AM IST